Neoplasms Metastasis Completed Phase 1 / 2 Trials for Trastuzumab (DB00072)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00317720Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast CancerTreatment